Advances in Biotechnology Short Notes
One-page CSIR NET revision for Advances in Biotechnology: cloning, editing, sequencing, transgenics, markers, tissue culture, marine and environmental biotech.
- 7 min
On this page · 11 sections
The three pages of the chapter on one sheet. For explanations and worked problems, go back to the chapter: Recombinant DNA, Genome Editing and Sequencing, Animal and Agricultural Biotechnology and Marine and Environmental Biotechnology. The medical biotechnology line is not covered in this chapter yet.
Formulas You Must Be Able to Use
| Formula | Use |
|---|---|
| Expected fragment length \(=4^{n}\) bp | Frequency of an n-bp restriction site (256, 4,096, 65,536 for 4, 6, 8 bp) |
| \(N = \ln(1-P)/\ln(1-f)\); \(N \approx 4.6/f\) at P = 0.99 | Clarke–Carbone library size |
| \(C = LN/G\) | Sequencing coverage |
| \(1-(1/2)^{n+1}\) | Expected recurrent-parent genome after n backcrosses: 75, 87.5, 93.75, 96.875% |
| \(R = h^2S\); \(\Delta G_{year} = i\,r\,\sigma_A/L\) | Selection response; annual genetic gain |
| LOD 3 | Odds of 1,000:1 for linkage |
| Removal (%) \(=(S_{in}-S_{out})/S_{in}\times100\) | BOD removal efficiency |
| HRT \(=V/Q\); SRT \(=VX/(Q_wX_r)\); F/M \(=QS_0/(VX)\) | Activated sludge |
| SVI \(=\) settled mL/L \(\times1000/\) MLSS (mg/L) | Settleability; above about 150 mL/g suggests bulking |
| Mixed C/N \(=\sum(\%C\cdot m)/\sum(\%N\cdot m)\) | Co-digestion feed mix (target 20–30:1) |
| Ethanol \(=2\times46.07/180.16=0.511\) g/g | Theoretical yield (CO₂ 0.489 g/g) |
| Dark fermentation \(\le4\) mol H₂/mol glucose | Acetate route; 2 mol on butyrate route |
| Mass of soil \(=\) area \(\times\) depth \(\times\) bulk density | Phytoextraction mass balance |
Cutting, Joining and Carrying
| Item | Fact |
|---|---|
| Restriction types | I (distant, random), II (within site), IIS (fixed distance outside), III (about 25 bp away) |
| Ends | EcoRI, BamHI, HindIII 5′ overhang; PstI, KpnI 3′ overhang; SmaI blunt; NotI 8-bp rare cutter |
| Compatible ends | BamHI/Sau3AI, SalI/XhoI; isoschizomers same site, neoschizomers different cut (SmaI/XmaI) |
| Dam/Dcm | Methylation blocks some enzymes; DpnI cuts only methylated GATC (QuikChange) |
| Ligation | T4 ligase uses ATP; dephosphorylate the vector; insert:vector about 3:1 |
| Scarless assembly | Gibson (exonuclease, polymerase, ligase); Golden Gate (Type IIS, one pot); Gateway (λ att, ccdB) |
| Vector capacity | Plasmid about 10 kb; λ 9–23 kb; cosmid 35–45 kb; PAC 100–150 kb; BAC 100–300 kb; YAC up to about 1 Mb |
| BAC vs YAC | BAC: F plasmid, 1–2 copies, stable. YAC: CEN, ARS, telomeres, chimerism |
| Screens | pBR322 insertional inactivation (Ampᴿ Tetˢ); pUC lacZα blue–white on X-gal/IPTG |
| Selection vs screening | Selection kills non-transformants; screening only marks them |
| Libraries | Genomic: partial digest, introns and promoters. cDNA: expressed, spliced, abundance-biased; normalised and subtractive variants |
Expression, Mutagenesis, Knockouts
| Item | Fact |
|---|---|
| E. coli | T7/BL21(DE3), IPTG; no glycans; inclusion bodies; periplasm export (pelB) helps disulfides |
| Pichia | AOX1 (methanol); hypermannosylation |
| Insect / mammalian | Baculovirus–Sf9 (paucimannose); CHO and HEK293 (human-like glycans) |
| Tags | His₆–Ni-NTA–imidazole; GST–glutathione; MBP–maltose; Strep-tag II–desthiobiotin; TEV cleaves ENLYFQ↓G |
| Site-directed mutagenesis | Hutchison–Smith; Kunkel (uracil template, dut⁻ ung⁻); QuikChange; overlap-extension PCR |
| Directed evolution | Error-prone PCR, DNA shuffling, saturation mutagenesis; alanine scanning asks which residues matter |
| Knockout | ES cells; neo positive, tk negative; chimera then germline (Nobel 2007: Capecchi, Evans, Smithies) |
| Cre-lox | loxP 34 bp; same orientation excision, opposite orientation inversion; FLP–FRT; CreER |
| Knockdown | siRNA/shRNA, Dicer, Argonaute/RISC; partial, reversible, off-target risk |
Genome Editing
| Item | Fact |
|---|---|
| ZFN | About 3 bp per finger; FokI dimer |
| TALEN | One repeat per base; NI = A, NG = T, HD = C, NN = G (or A); FokI dimer |
| Cas9 | sgRNA 20-nt spacer; NGG PAM 3′ of protospacer; HNH and RuvC; blunt cut about 3 bp from PAM |
| Cas12a | crRNA only; TTTV PAM 5′; RuvC; staggered 5′ overhangs |
| Cas13 | Targets RNA (HEPN) |
| NHEJ | Indels, default, all phases (Ku70/80, DNA-PKcs, LigIV–XRCC4) |
| HDR | Precise with a donor; S/G2 only; inefficient |
| MMEJ | Deletions between microhomologies |
| Base editors | CBE C•G to T•A; ABE A•T to G•C (evolved TadA); no double-strand break, transitions only |
| Prime editor | Cas9 H840A nickase plus reverse transcriptase plus pegRNA; small insertions, deletions, all substitutions |
| Nobel 2020 | Charpentier and Doudna |
Sequencing
| Platform | Fact |
|---|---|
| Sanger | ddNTP, capillary, up to about 1 kb; confirmation standard |
| Illumina | Reversible terminators; short (50–300 bp); highest throughput and accuracy; struggles with repeats |
| Ion Torrent | H⁺ release; homopolymer indel errors |
| PacBio | ZMW; HiFi circular consensus; long and accurate |
| Nanopore | Ionic current; ultra-long; highest raw error; native base modifications and direct RNA |
| Strategy | Depth buys base accuracy, read length buys structure; hybrids win |
Animal Biotechnology
| Item | Fact |
|---|---|
| Transgenic routes | Pronuclear injection (random); ES-cell targeting (precise); SCNT; zygote editing; founders often mosaic |
| SCNT | Low efficiency, incomplete reprogramming, large offspring syndrome |
| Pharming | Mammary promoters (β-casein, whey acidic protein) |
| Breeding | AI (male intensity); MOET and OPU–IVF (female intensity, shorter interval); sexed semen; BLUP; genomic selection |
| Cryopreservation | Slow freezing versus vitrification; permeating (glycerol, DMSO, ethylene glycol) versus non-permeating (sucrose, trehalose); survival versus cooling rate is an inverted U |
| Cell lines | Primary, finite diploid (Hayflick about 50), continuous aneuploid (contact inhibition and anchorage dependence lost) |
| Culture practice | DMEM, RPMI; 5–10% FBS; bicarbonate and 5% CO₂; trypsin–EDTA; 10% DMSO, slow freeze, fast thaw; STR authentication |
Agricultural Biotechnology
| Item | Fact |
|---|---|
| Agrobacterium | T-DNA defined by 25-bp borders; vir genes in trans; acetosyringone; binary versus co-integrate |
| Biolistics | Species-independent; plastid transformation; multi-copy insertions |
| Markers | nptII, hpt, bar; GUS, GFP, luciferase |
| Bt | Protoxin, alkaline midgut, proteases, receptor binding, pore; refuge plus pyramiding |
| Herbicide tolerance | CP4 EPSPS (glyphosate); bar/PAT (glufosinate, glutamine synthetase) |
| Golden Rice | psy plus bacterial crtI, β-carotene in endosperm |
| India | Rules 1989 under the EP Act 1986; IBSC, RCGM, GEAC; Bt cotton; Bt brinjal moratorium 2010; check current notifications for DMH-11 and SDN-1/2 genome-editing exemptions |
| ESTs | Single-pass partial cDNA reads; unigenes, EST-SSRs |
| Marker dominance | Dominant: RAPD, AFLP. Co-dominant: RFLP, SSR, SNP |
| MABC | Foreground, recombinant (breaks linkage drag), background selection |
| Tissue culture | Totipotency; MS medium; high auxin roots, high cytokinin shoots, balanced callus |
| Culture routes | Micropropagation, organogenesis, somatic embryogenesis, meristem culture (virus-free), anther culture (haploid then doubled haploid), endosperm (triploid), embryo rescue |
| Protoplasts | Cellulase and pectinase in osmoticum; PEG or electrofusion; somatic hybrid (both nuclei) versus cybrid (one nucleus, other cytoplasm) |
| Plantibodies | Plant glycans: xylose, α1,3-fucose, no sialic acid; glyco-engineering; taliglucerase alfa from carrot cells |
Marine Biotechnology
| Item | Fact |
|---|---|
| Algal products | Agar (Gelidium, Gracilaria), carrageenan (Chondrus, Kappaphycus), alginate (brown algae), β-carotene (Dunaliella) |
| Marine drugs | Cytarabine (sponge nucleosides), ziconotide (Conus magus, N-type Ca²⁺), trabectedin (tunicate), eribulin (halichondrin B), auristatin payloads (dolastatin lineage) |
| Tools | Tetrodotoxin and saxitoxin (Na⁺ channels), okadaic acid (PP1/PP2A), GFP from Aequorea (Nobel 2008) |
| Supply problem | Synthesis, semisynthesis, culture, heterologous expression; many metabolites are symbiont products |
| Biofilm | Conditioning film, reversible, irreversible, microcolony, maturation, dispersal; high c-di-GMP is sessile; tolerance not resistance |
| Biofouling | Conditioning film, microfouling, macrofouling; TBT prohibited; copper and foul-release coatings |
Environmental Biotechnology
| Item | Fact |
|---|---|
| BOD vs COD | BOD₅ at 20 °C, biological; COD chemical, COD ≥ BOD; BOD/COD > 0.5 readily biodegradable |
| Treatment stages | Preliminary, primary (settling), secondary (biological), tertiary (nutrients, disinfection) |
| Activated sludge | Recycle decouples SRT from HRT; bulking (high SVI), foaming, rising sludge (denitrification) |
| Nitrogen | Nitrification (aerobic, slow, long SRT), denitrification (anoxic), anammox |
| Anaerobic digestion | Hydrolysis, acidogenesis, acetogenesis, methanogenesis; syntrophic H₂ transfer; 35 °C or 55 °C; UASB |
| Biofertilizers | Rhizobium symbiotic; Azotobacter free-living; Azospirillum associative; cyanobacteria and Azolla for rice; Frankia for trees; AM fungi improve P, do not fix N |
| Biopesticides | Bt (kurstaki, israelensis); Trichoderma (mycoparasitism, ISR); Pseudomonas fluorescens; Beauveria/Metarhizium; neem azadirachtin; pheromones |
| Biofuels | 1st food crops; 2nd lignocellulose (pretreatment, cellulase, pentoses); 3rd algae (harvest cost); biodiesel by transesterification; biogas; biohydrogen routes |
| Bioremediation | Biostimulation feeds natives; bioaugmentation seeds new organisms; in situ versus ex situ; bioventing versus biosparging |
| Recalcitrants | PCBs (anaerobic then aerobic), TCE (Dehalococcoides), PAHs (bioavailability), PET hydrolase |
| Metals | Never degraded; biosorption, bioleaching, Cr(VI) to Cr(III), sulfide precipitation |
| Phytoremediation | Phytoextraction (removes), rhizofiltration, phytostabilisation (locks), phytodegradation, rhizodegradation, phytovolatilisation |
| Hyperaccumulators | Above about 1,000 µg/g (Ni, Cu, Pb), 10,000 (Zn, Mn), 100 (Cd) in shoots |
Last-Minute Traps
Keep Going
- Next unit in the syllabus order: Methods in Biology — the analytical techniques behind every readout in this chapter.
- Related: Biochemical Engineering and Industrial Biotechnology for scale-up of cloned products.
- Part A practice for the numericals: Numerical Ability.